Skip to main content
Top
Published in: Gastric Cancer 1/2014

01-01-2014 | Original Article

Incidence of metachronous gastric cancer in the remnant stomach after synchronous multiple cancer surgery

Authors: Isao Nozaki, Shinji Hato, Takaya Kobatake, Koji Ohta, Yoshirou Kubo, Rieko Nishimura, Akira Kurita

Published in: Gastric Cancer | Issue 1/2014

Login to get access

Abstract

Background

In the preoperative evaluation for gastric cancer, high-resolution endoscopic technologies allow us to detect small accessory lesions. However, it is not known if the gastric remnant after partial gastrectomy for synchronous multiple gastric cancers has a greater risk for metachronous cancer. The purpose of this study was to determine the incidence of metachronous cancer in this patient subset compared with that after solitary cancer surgery.

Methods

Data on a consecutive series of 1,281 patients gastrectomized for early gastric cancer from 1991 to 2007 were analyzed retrospectively. The 715 gastric remnants after distal gastrectomy were periodically surveyed by endoscopic examination in Shikoku Cancer Center. Among those surveyed cases, 642 patients were pathologically diagnosed with solitary lesion (SO group) and 73 patients with synchronous multiple lesions (MU group) at the time of the initial surgery.

Results

In the follow-up period, 15 patients in the SO group and 3 patients in the MU group were diagnosed as having metachronous cancer in the gastric remnant. The cumulative 4-year incidence rate was 1.9 % in the SO group and 5.5 % in the MU group. The difference did not reach the significant level by the log-rank test.

Conclusions

The incidence of metachronous cancer is higher after multiple cancer surgery; however, the difference is not statistically significant.
Literature
1.
go back to reference Ikeda Y, Saku M, Kishihara F, Maehara Y. Effective follow-up for recurrence or a second primary cancer in patients with early gastric cancer. Br J Surg. 2005;92:235–9.PubMedCrossRef Ikeda Y, Saku M, Kishihara F, Maehara Y. Effective follow-up for recurrence or a second primary cancer in patients with early gastric cancer. Br J Surg. 2005;92:235–9.PubMedCrossRef
2.
go back to reference Furukawa H, Iwanaga T, Hiratsuka M, Imaoka S, Ishikawa O, Kabuto T, et al. Gastric remnant cancer as a metachronous multiple lesion. Br J Surg. 1993;80:54–6.PubMedCrossRef Furukawa H, Iwanaga T, Hiratsuka M, Imaoka S, Ishikawa O, Kabuto T, et al. Gastric remnant cancer as a metachronous multiple lesion. Br J Surg. 1993;80:54–6.PubMedCrossRef
3.
go back to reference Nozaki I, Kurita A, Nasu J, Kubo Y, Aogi K, Tanada M, et al. Higher incidence of gastric remnant cancer after proximal than distal gastrectomy. Hepatogastroenterology. 2007;54:1604–8.PubMed Nozaki I, Kurita A, Nasu J, Kubo Y, Aogi K, Tanada M, et al. Higher incidence of gastric remnant cancer after proximal than distal gastrectomy. Hepatogastroenterology. 2007;54:1604–8.PubMed
4.
go back to reference Nozaki I, Nasu J, Kubo Y, Tanada M, Nishimura R, Kurita A. Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery. World J Surg. 2010;34:1548–54.PubMedCrossRef Nozaki I, Nasu J, Kubo Y, Tanada M, Nishimura R, Kurita A. Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery. World J Surg. 2010;34:1548–54.PubMedCrossRef
5.
go back to reference Onodera H, Tokunaga A, Yoshiyuki T, Kiyama T, Kato S, Matsukura N, et al. Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer. Hepatogastroenterology. 2004;51:82–5.PubMed Onodera H, Tokunaga A, Yoshiyuki T, Kiyama T, Kato S, Matsukura N, et al. Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer. Hepatogastroenterology. 2004;51:82–5.PubMed
6.
go back to reference Hosokawa O, Kaizaki Y, Watanabe K, Hattori M, Douden K, Hayashi H, et al. Endoscopic surveillance for gastric remnant cancer after early cancer surgery. Endoscopy. 2002;34:469–73.PubMedCrossRef Hosokawa O, Kaizaki Y, Watanabe K, Hattori M, Douden K, Hayashi H, et al. Endoscopic surveillance for gastric remnant cancer after early cancer surgery. Endoscopy. 2002;34:469–73.PubMedCrossRef
7.
go back to reference Yamagiwa H, Yoshimura H, Matsuzaki O, Ishihara A. Pathological study of multiple gastric carcinoma. Acta Pathol Jpn. 1980;30:421–6.PubMed Yamagiwa H, Yoshimura H, Matsuzaki O, Ishihara A. Pathological study of multiple gastric carcinoma. Acta Pathol Jpn. 1980;30:421–6.PubMed
8.
go back to reference Kim DY, Joo JK, Ryu SY, Park YK, Kim YJ, Kim SK. Clinicopathologic characteristics of gastric carcinoma in elderly patients: a comparison with young patients. World J Gastroenterol. 2005;11:22–6.PubMed Kim DY, Joo JK, Ryu SY, Park YK, Kim YJ, Kim SK. Clinicopathologic characteristics of gastric carcinoma in elderly patients: a comparison with young patients. World J Gastroenterol. 2005;11:22–6.PubMed
9.
go back to reference Kodama M, Tur GE, Shiozawa N, Koyama K. Clinicopathological features of multiple primary gastric carcinoma. J Surg Oncol. 1996;62:57–61.PubMedCrossRef Kodama M, Tur GE, Shiozawa N, Koyama K. Clinicopathological features of multiple primary gastric carcinoma. J Surg Oncol. 1996;62:57–61.PubMedCrossRef
10.
go back to reference Kosaka T, Miwa K, Yonemura Y, Urade M, Ishida T, Takegawa S, et al. A clinicopathologic study on multiple gastric cancers with special reference to distal gastrectomy. Cancer (Phila). 1990;65:2602–5.CrossRef Kosaka T, Miwa K, Yonemura Y, Urade M, Ishida T, Takegawa S, et al. A clinicopathologic study on multiple gastric cancers with special reference to distal gastrectomy. Cancer (Phila). 1990;65:2602–5.CrossRef
11.
go back to reference Fujita T, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kinoshita T. Clinical and histopathological features of remnant gastric cancers, after gastrectomy for synchronous multiple gastric cancers. J Surg Oncol. 2009;100:466–71.PubMedCrossRef Fujita T, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kinoshita T. Clinical and histopathological features of remnant gastric cancers, after gastrectomy for synchronous multiple gastric cancers. J Surg Oncol. 2009;100:466–71.PubMedCrossRef
12.
go back to reference Esaki Y, Hirokawa K, Yamashiro M. Multiple gastric cancers in the aged with special reference to intramucosal cancers. Cancer (Phila). 1987;59:560–5.CrossRef Esaki Y, Hirokawa K, Yamashiro M. Multiple gastric cancers in the aged with special reference to intramucosal cancers. Cancer (Phila). 1987;59:560–5.CrossRef
13.
go back to reference Lee HL, Eun CS, Lee OY, Han DS, Yoon BC, Choi HS, et al. When do we miss synchronous gastric neoplasms with endoscopy? Gastrointest Endosc. 2010;71:1159–65.PubMedCrossRef Lee HL, Eun CS, Lee OY, Han DS, Yoon BC, Choi HS, et al. When do we miss synchronous gastric neoplasms with endoscopy? Gastrointest Endosc. 2010;71:1159–65.PubMedCrossRef
14.
go back to reference Honmyo U, Misumi A, Murakami A, Haga Y, Akagi M. Clinicopathological analysis of synchronous multiple gastric carcinoma. Eur J Surg Oncol. 1989;15:316–21.PubMed Honmyo U, Misumi A, Murakami A, Haga Y, Akagi M. Clinicopathological analysis of synchronous multiple gastric carcinoma. Eur J Surg Oncol. 1989;15:316–21.PubMed
15.
go back to reference Yanadori E, Oguma H, Sasagawa T, Kitamura Y, Takasaki K. Clinicopathological study of multifocal gastric cancer. Jpn J Gastroenterol Surg. 2001;34:9–14 (in Japanese).CrossRef Yanadori E, Oguma H, Sasagawa T, Kitamura Y, Takasaki K. Clinicopathological study of multifocal gastric cancer. Jpn J Gastroenterol Surg. 2001;34:9–14 (in Japanese).CrossRef
16.
go back to reference Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, et al. Considerations on the management of multiple gastric cancer from the viewpoint of postoperative surveillance and diagnosis of remnant cancer. Jpn J Gastroenterol Surg. 1995;28:2092–6 (in Japanese).CrossRef Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, et al. Considerations on the management of multiple gastric cancer from the viewpoint of postoperative surveillance and diagnosis of remnant cancer. Jpn J Gastroenterol Surg. 1995;28:2092–6 (in Japanese).CrossRef
17.
go back to reference Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.CrossRef Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.CrossRef
18.
go back to reference Maruyama K, Kaminishi M, Hayashi K, Isobe Y, Honda I, Katai H, et al. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer. 2006;9:51–66.PubMedCrossRef Maruyama K, Kaminishi M, Hayashi K, Isobe Y, Honda I, Katai H, et al. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer. 2006;9:51–66.PubMedCrossRef
19.
go back to reference Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma—2nd English edition. Gastric Cancer. 1998;1:10–24.PubMedCrossRef Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma—2nd English edition. Gastric Cancer. 1998;1:10–24.PubMedCrossRef
20.
go back to reference Moertel CG, Bargen JA, Soule EH. Multiple gastric cancers: review of the literature and study of 42 cases. Gastroenterology. 1957;32:1095–103.PubMed Moertel CG, Bargen JA, Soule EH. Multiple gastric cancers: review of the literature and study of 42 cases. Gastroenterology. 1957;32:1095–103.PubMed
21.
go back to reference Nitta T, Egashira Y, Akutagawa H, Edagawa G, Kurisu Y, Nomura E, et al. Study of clinicopathological factors associated with the occurrence of synchronous multiple gastric carcinomas. Gastric Cancer. 2009;12:23–30.PubMedCrossRef Nitta T, Egashira Y, Akutagawa H, Edagawa G, Kurisu Y, Nomura E, et al. Study of clinicopathological factors associated with the occurrence of synchronous multiple gastric carcinomas. Gastric Cancer. 2009;12:23–30.PubMedCrossRef
22.
go back to reference Lee IS, Park YS, Kim KC, Kim TH, Kim HS, Choi KD, et al. Multiple synchronous early gastric cancers: high-risk group and proper management. Surg Oncol. 2012;21:269–73.PubMedCrossRef Lee IS, Park YS, Kim KC, Kim TH, Kim HS, Choi KD, et al. Multiple synchronous early gastric cancers: high-risk group and proper management. Surg Oncol. 2012;21:269–73.PubMedCrossRef
23.
go back to reference Peng J, Wang Y. Epidemiology, pathology and clinical management of multiple gastric cancers: a mini-review. Surg Oncol. 2010;19:e110–4.PubMedCrossRef Peng J, Wang Y. Epidemiology, pathology and clinical management of multiple gastric cancers: a mini-review. Surg Oncol. 2010;19:e110–4.PubMedCrossRef
24.
go back to reference Nasu J, Doi T, Endo H, Nishina T, Hirasaki S, Hyodo I. Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection. Endoscopy. 2005;37:990–3.PubMedCrossRef Nasu J, Doi T, Endo H, Nishina T, Hirasaki S, Hyodo I. Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection. Endoscopy. 2005;37:990–3.PubMedCrossRef
25.
go back to reference Matsukura N, Tajiri T, Kato S, Togashi A, Masuda G, Fujita I, et al. Helicobacter pylori eradication therapy for the remnant stomach after gastrectomy. Gastric Cancer. 2003;6:100–7.PubMed Matsukura N, Tajiri T, Kato S, Togashi A, Masuda G, Fujita I, et al. Helicobacter pylori eradication therapy for the remnant stomach after gastrectomy. Gastric Cancer. 2003;6:100–7.PubMed
26.
go back to reference Nakagawara H, Miwa K, Nakamura S, Hattori T. Duodenogastric reflux sustains Helicobacter pylori infection in the gastric stump. Scand J Gastroenterol. 2003;38:931–7.PubMedCrossRef Nakagawara H, Miwa K, Nakamura S, Hattori T. Duodenogastric reflux sustains Helicobacter pylori infection in the gastric stump. Scand J Gastroenterol. 2003;38:931–7.PubMedCrossRef
27.
go back to reference Onoda N, Maeda K, Sawada T, Wakasa K, Arakawa T, Chung KH. Prevalence of Helicobacter pylori infection in gastric remnant after distal gastrectomy for primary gastric cancer. Gastric Cancer. 2001;4:87–92.PubMedCrossRef Onoda N, Maeda K, Sawada T, Wakasa K, Arakawa T, Chung KH. Prevalence of Helicobacter pylori infection in gastric remnant after distal gastrectomy for primary gastric cancer. Gastric Cancer. 2001;4:87–92.PubMedCrossRef
28.
go back to reference Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392–7.PubMedCrossRef Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392–7.PubMedCrossRef
29.
go back to reference Shiotani A, Uedo N, Iishi H, Yoshiyuki Y, Ishii M, Manabe N, et al. Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication. Digestion. 2008;78:113–9.PubMedCrossRef Shiotani A, Uedo N, Iishi H, Yoshiyuki Y, Ishii M, Manabe N, et al. Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication. Digestion. 2008;78:113–9.PubMedCrossRef
30.
go back to reference Matsuo T, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama K. Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter. 2011;16:415–9.PubMedCrossRef Matsuo T, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama K. Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter. 2011;16:415–9.PubMedCrossRef
31.
go back to reference Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992;102:760–6.PubMed Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992;102:760–6.PubMed
32.
go back to reference Domellof L. Gastric carcinoma promoted by alkaline reflux gastritis—with special reference to bile and other surfactants as promoters of postoperative gastric cancer. Med Hypotheses. 1979;5:463–76.PubMedCrossRef Domellof L. Gastric carcinoma promoted by alkaline reflux gastritis—with special reference to bile and other surfactants as promoters of postoperative gastric cancer. Med Hypotheses. 1979;5:463–76.PubMedCrossRef
33.
go back to reference Tersmette AC, Offerhaus GJ, Tersmette KW, Giardiello FM, Moore GW, Tytgat GN, et al. Meta-analysis of the risk of gastric stump cancer: detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions. Cancer Res. 1990;50:6486–9.PubMed Tersmette AC, Offerhaus GJ, Tersmette KW, Giardiello FM, Moore GW, Tytgat GN, et al. Meta-analysis of the risk of gastric stump cancer: detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions. Cancer Res. 1990;50:6486–9.PubMed
34.
go back to reference Fujita T, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kinoshita T. Relationship between the histological type of initial lesions and the risk for the development of remnant gastric cancers after gastrectomy for synchronous multiple gastric cancers. World J Surg. 2010;34:296–302.PubMedCrossRef Fujita T, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kinoshita T. Relationship between the histological type of initial lesions and the risk for the development of remnant gastric cancers after gastrectomy for synchronous multiple gastric cancers. World J Surg. 2010;34:296–302.PubMedCrossRef
Metadata
Title
Incidence of metachronous gastric cancer in the remnant stomach after synchronous multiple cancer surgery
Authors
Isao Nozaki
Shinji Hato
Takaya Kobatake
Koji Ohta
Yoshirou Kubo
Rieko Nishimura
Akira Kurita
Publication date
01-01-2014
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 1/2014
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-013-0261-y

Other articles of this Issue 1/2014

Gastric Cancer 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.